You are here

AstraZeneca

Alexion Investors Approve Acquisition By AstraZeneca

Yahoo/SmarterAnalyst

Wed, 05/12/21 - 10:46 am

Validation for a drug class, and for Sanofi

EP Vantage

Wed, 05/12/21 - 10:44 am

AstraZeneca plan to beef up CEO Soriot's pay packet faces scrutiny at AGM

Yahoo/Reuters

Mon, 05/10/21 - 09:44 am

AstraZeneca, Daiichi Sankyo uncork new TNBC data for 2nd partnered ADC — and it's adding more heat under Gilead's Trodelvy

Endpoints

Sun, 05/9/21 - 10:58 pm

antibody-drug conjugate

Glass half-full? Embattled AstraZeneca CEO Soriot defends COVID-19 vaccine

Fierce Pharma

Mon, 05/3/21 - 10:53 am

Emergency Use Authorization

AstraZeneca's big CKD promises come to fruition as Farxiga wins approval in patients regardless of diabetes status

Endpoints

Mon, 05/3/21 - 10:45 am

chronic kidney disease

AstraZeneca's diabetes drug Farxiga nabs coveted kidney disease nod, way ahead of rival Jardiance

Fierce Pharma

Sat, 05/1/21 - 09:23 pm

chronic kidney disease

AstraZeneca Hits Another Bump in the Road to COVID-19 Vaccine Approval in the US

BioSpace

Sat, 05/1/21 - 09:14 pm

AstraZeneca drops BCMA drug after seeing early clinical data

Fierce Biotech

Fri, 04/30/21 - 10:35 am

antibody-drug conjugate

Multiple Myeloma

AZ posts solid Q1 results as Alexion merger looms

Pharmforum

Fri, 04/30/21 - 10:27 am

Top U.S. trade negotiator meets Pfizer, AstraZeneca execs on COVID-19 IP waiver

Reuters

Tue, 04/27/21 - 11:29 pm

intellectual property

This Huge Win Could Boost Novavax's Fortunes -- and It Has Nothing to Do With COVID-19

Motley Fool

Tue, 04/27/21 - 10:44 am

U.S. Will Export up to 60 Million Doses of AstraZeneca Coronavirus Vaccine

Motley Fool

Mon, 04/26/21 - 11:10 pm

AstraZeneca drives biomarker testing with a string of efforts—and a new leader

Fierce Pharma

Mon, 04/26/21 - 11:02 pm

biomarker testing

AstraZeneca and Sanofi Announce Big Breakthrough With RSV Vaccine

BioSpace

Mon, 04/26/21 - 10:41 am

clinical trials

A look ahead at the FDA meeting that could decide the future of 6 cancer drug approvals

BioPharma Dive

Thu, 04/22/21 - 11:52 pm

cancer immunotherapy

Bristol Myers Squibb

Pfizer and BioNTech Vaccine Sales Jump $1.4 Billion Thanks to AstraZeneca's Blunders

Motley Fool

Thu, 04/22/21 - 10:44 am

With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine

Fierce Pharma

Wed, 04/21/21 - 11:24 pm

Emergency Use Authorization

Combining AstraZeneca's 'good' cholesterol booster with PCSK9 inhibition shows promise in heart disease

Fierce Biotech

Wed, 04/21/21 - 11:23 pm

As fears mount over J&J and AstraZeneca, Novavax enters a shaky spotlight

Endpoints

Wed, 04/21/21 - 11:20 pm

Pages